Amnestix, Inc.

Amnestix is an early-stage bio-pharmaceutical company focused on cognitive enhancement. The company was founded on the discoveries of researchers of the Translational Genomics Institute (TGen) in Phoenix, Arizona and of the University of Zurich, Switzerland. Year of foundation: 2006